From: DCHAS Membership Chair <membership**At_Symbol_Here**DCHAS.ORG>
Subject: [DCHAS-L] Novel coronavirus found in surprisingly high levels in sewage
Date: Fri, 17 Apr 2020 08:03:01 -0400
Reply-To: ACS Division of Chemical Health and Safety <DCHAS-L**At_Symbol_Here**PRINCETON.EDU>
Message-ID: 17A06EF4-2E06-4986-ACC8-68A64F13BF7C**At_Symbol_Here**

Novel coronavirus found in surprisingly high levels in sewage

Viral levels higher than expected based on confirmed COVID-19 cases

Because SARS-CoV-2, the novel coronavirus that causes COVID-19, has been found in the feces of confirmed COVID-19 patients, wastewater-based epidemiology might be an effective way to track the extent of the disease in a population.

Wastewater epidemiology is most commonly used to monitor drug usage in a community. It can also provide information about the spread of infection when individual tests are limited. A team led by Eric J. Alm of the Massachusetts Institute of Technology and Biobot Analytics has now used quantitative reverse transcription polymerase chain reaction (RT-PCR) to measure SARS-CoV-2 in sewage from a wastewater treatment facility in Massachusetts (medRxiv 2020, DOI: 10.1101/2020.04.05.20051540).

The Biobot team analyzed four samples taken before the first known US case of COVID-19, and all tested negative for the virus. All 10 samples taken between March 18 and March 25 tested positive for SARS-CoV-2, at levels higher than the researchers expected based on the number of confirmed cases. They used direct DNA sequencing to verify that the RT-PCR products were actually from SARS-CoV-2. But more information is needed, such as the amount of virus in stool from positive patients over the course of the disease, to fully interpret the findings.
Wastewater analysis ‰??could be used to establish whether COVID-19 has infected a community and monitor for when the community is relatively free of COVID-19,‰?? says Kevin Thomas, an epidemiologist at the University of Queensland. The approach should be used in combination with individual testing, he says.

Biobot is now getting weekly samples from more than 100 treatment plants around the US, according to Mariana Matus, Biobot‰??s CEO.

For more information about the DCHAS-L e-mail list, contact the Divisional membership chair at membership**At_Symbol_Here**
Follow us on Twitter **At_Symbol_Here**acsdchas

Previous post   |  Top of Page   |   Next post

The content of this page reflects the personal opinion(s) of the author(s) only, not the American Chemical Society, ILPI, Safety Emporium, or any other party. Use of any information on this page is at the reader's own risk. Unauthorized reproduction of these materials is prohibited. Send questions/comments about the archive to
The maintenance and hosting of the DCHAS-L archive is provided through the generous support of Safety Emporium.